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In this issue of Thorax,1 Samuel Brown and colleagues present their result on early identification of 
physical, cognitive, and mental health outcome subtypes in patients who survived Acute 
Respiratory Distress Syndrome (ARDS). Using data from the ARDSNet Long-Term Outcomes Study 
(ALTOS), the authors identified a group of 645 patients who had been studied with a 
comprehensive battery of validated health outcome instruments, which included measures of 
physical, cognitive and mental health (anxiety, depression, and posttraumatic stress disorder), as 
well as quality of life status, obtained at 6-month follow-up. After splitting the data into derivation 
and validation datasets, the authors used a data mining approach, weighted network analysis, to 
identify and validate four outcome sub-phenotypes. They identified 4 sub-types: 1) mildly 
impaired physical and mental health status; 2) moderately impaired physical and mental health 
status; 3) severely impaired physical and moderately impaired mental health status; and 4) 
severely impaired physical and mental health status. In each of the 4 subtypes, one third of 
patients suffered a significant decrease from baseline in their health state measured with the EQ-
5D or SF36. Separation of outcome subtypes in relation to various instruments of physical and 
mental health assessment was good, while cognitive function evaluated with Mini-Mental State 
Exam did not differ significantly across subtypes. Cognitive outcomes remained unrelated to the 
subtypes defined by physical and mental health outcomes also when using a battery of more 
detailed cognitive tests available for a subset of patients. This multi-center study confirms that 
ARDS is associated with long-lasting disability after the resolution of the acute condition: fewer 
than half of patients were living at home independently at 6 months compared to 91% at baseline. 
Physical and mental impairments were both severe in one quarter of them, who were mainly 
female, current smokers and of Latino ethnicity. 
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Among 144 variables available at baseline, a previous study by the same authors had identified 
nine predictors associated with health status at 6-month follow-up:2 age, female sex, Latino 
ethnicity, current smoking, body mass index, pulmonary comorbidity, AIDS comorbidity, nadir 
respiratory rate, and residential independence. In this paper, five of these nine variables 
independently predicted physical and mental outcome subtypes in ARDS survivors: female sex, 
Latino ethnicity, pulmonary comorbidity, current smoker, and residential independence. Of note, 
variables related to acute illness severity and measured at the time of enrollment (APACHE 3 
scores, shock at enrollment, sepsis as primary cause of ARDS, PaO2/FIO2 ratio, PEEP, Glasgow 
Coma Scale score) as well as age and ICU length of stay did not predict long-term functional 
outcome subtypes in ARDS survivors. A first message of this study is that the predictors of acute 
mortality and those of long-term disability can be different. If this is confirmed in future studies, 
we would be encouraged to do absolutely everything we can to make ARDS patients survive the 
acute illness, knowing that a good long-term functional outcome may still be possible even in 
older individuals with high disease severity. 
 
A second message is that early prediction of long-term outcome subtypes in ARDS patients is 
feasible. Subtyping, defined as recognition of aggregated patterns of observable clinical, 
radiological, biochemical and physiological characteristics within a heterogeneous cohort of 
patients, is an integral part of clinical practice, and has always been used by physicians to select 
those patients that are more likely to respond to treatment in case of protean disease. In the 
historical trial on streptomycin treatment of pulmonary tuberculosis, “a first prerequisite [required 
by investigators] was that all patients in the trial should have a similar type of disease”.3 After 
having defined disease features, they commented: “Such closely defined features were considered 
indispensable, for it was realized that no two patients have an identical form of the disease, and it 
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was desired to eliminate as many of the obvious variations as possible”.3 This perfectly expresses 
the reason why such operational subtyping is on the way of personalized medicine, which starts at 
the population level and uses “various approaches and disciplines to characterize subsets on 
subsets of such patients, ending with the individual patient”.4 With the availability of large 
datasets and powerful statistical analysis tools of modern times, this medical art of clinical pattern 
recognition has become science and is currently applied in many fields of medicine. The 
importance of ARDS subtyping has been demonstrated in some recent studies showing for 
example the selective effect of prone positioning in severe ARDS: a reduction in mortality could be 
demonstrated only when this treatment was targeted at ARDS patients with a PaO2/FiO2 ratio 
≤150 rather than all ARDS patients.5 Another example is the selective response to PEEP in ARDS 
patients with hyper-inflammatory profile, characterized by high plasma levels of inflammatory 
biomarkers, profound shock, low serum bicarbonate, and a high prevalence of sepsis as the cause 
of ARDS.6 ARDS subtypes have also been shown to have a differential response to randomly 
assigned fluid management strategy, with patients with hyper-inflammatory profile showing 
reduced mortality with a conservative strategy.7 However, the main scope of these studies was to 
identify subtypes of ARDS patients with different hospital mortality, and not with different long-
term disability as in the current study. 
 
Identifying outcome subtypes does not necessarily imply the identification of their underlying 
pathogenetic mechanisms. When this happens, people refer to “endotypes”, i.e. subtypes of a 
disease with distinct pathophysiological mechanisms that can be targeted by selective treatment.4 
Brown’s study did not assess pathophysiological mechanisms, and hence it should be considered a 
preliminary step towards full characterization of ARDS long-term outcomes with potentially 
distinct response to treatment, as the authors acknowledge. However, the fact that predictors of 
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physical and mental impairment did not predict cognitive impairment strongly suggests different 
pathophysiological mechanisms underlying cognitive and non-cognitive outcomes. This is in line 
with findings from a recent Canadian study,8 and represents a further important result of the 
study by Brown and colleagues. 
 
Possible explanations for this difference in pathophysiological mechanisms remain speculative. In 
critically ill patients, delirium is a strong predictor of cognitive impairment that persists for months 
to years after ICU discharge.9 Moreover, delirium is associated with brain atrophy10 and, in 
postoperative patients, with brain microstructural abnormalities reflecting diffuse cerebral white 
matter damage.11 Early ICU physical rehabilitation is associated with reduced incidence and 
shorter duration of delirium,12 13 and hence, it is tempting to speculate that rehabilitation may also 
be beneficial in reducing post-ICU cognitive impairment. Delirium and immobility potentiate each 
other,14 and therefore, early mobilization in the ICU may exert its beneficial effect by interrupting 
this vicious circle. However, rehabilitation may be ineffective in patients with severe ischemic 
brain disease or, at the other end of severity spectrum, in those with transient delirium associated 
with sedation. Future studies in patients with ARDS should consider the assessment of delirium 
during the ICU stay as a high priority in order to identify the mechanisms underlying its effect on 
long-term cognitive impairment and to evaluate the impact of early ICU mobilization on delirium 
and long-term cognition. 
 
ARDS is a potentially lethal, inflammatory lung disease, with hospital mortality varying between 
35% in milder forms to 46% in severe forms.15 It is therefore reasonable that researchers prioritize 
their efforts on developing strategies to reduce mortality. However, survivors of ARDS may suffer 
from long-term physical impairments, exercise limitations, profound neuromuscular weakness, 
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pain and fatigue,14 cognitive and psychiatric morbidity,16 decreased physical quality of life, a 
negative impact on employment and family income,17 and increased costs and use of health care 
services.18 Care is often provided by family members, for many of whom the occurrence of 
depressive symptoms is high19 and the impact on employment is negative.17 
 
The “A” of the acronym ARDS has changed over time from indicating “Adult” to indicating “Acute”. 
After 50 years since the first description of this syndrome,20 the time has come that we start 
considering the “A” as also indicating “After”. This would emphasize the need to address early 
survivorship care aimed at preventing disability after ICU20 with the same high priority that is given 
to the treatment of the acute lung injury to reduce mortality.  By identifying baseline 
characteristics that can predict at the time of ICU admission the risk of developing long-term 
physical and mental impairment if the patient survives the acute phase, the study by Brown and 
colleagues represents an important step toward this end.  
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